Matches in Wikidata for { <http://www.wikidata.org/entity/Q95290767> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q95290767 description "article scientifique publié en 2020" @default.
- Q95290767 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95290767 description "scientific article published on 01 May 2020" @default.
- Q95290767 description "wetenschappelijk artikel" @default.
- Q95290767 description "наукова стаття, опублікована 1 травня 2020" @default.
- Q95290767 description "գիտական հոդված հրատարակված 2020 թվականի մայիսի 1-ին" @default.
- Q95290767 name "Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries" @default.
- Q95290767 name "Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries" @default.
- Q95290767 type Item @default.
- Q95290767 label "Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries" @default.
- Q95290767 label "Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries" @default.
- Q95290767 prefLabel "Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries" @default.
- Q95290767 prefLabel "Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries" @default.
- Q95290767 P1433 Q95290767-8C2241DB-FEB3-457A-ABB5-CFB1BC108A4B @default.
- Q95290767 P1476 Q95290767-6FC463FA-8A1B-4EFC-A1D9-2EB95EBE3ED8 @default.
- Q95290767 P2093 Q95290767-2C29EBC0-E861-4BF2-8AA3-E7EF59C047A1 @default.
- Q95290767 P2093 Q95290767-2FBE23A7-E90A-48DC-B81A-9900D1D2BA55 @default.
- Q95290767 P2093 Q95290767-33E1EB32-A354-452D-BE68-867B15C4590A @default.
- Q95290767 P2093 Q95290767-54B33042-F08A-4017-933D-F3F38AA2BC38 @default.
- Q95290767 P2093 Q95290767-9F978334-ED7E-4258-98C5-6EACBDB4FF8A @default.
- Q95290767 P2093 Q95290767-AAC8D7A8-1562-4CEB-B326-CF81036BBDD8 @default.
- Q95290767 P2093 Q95290767-B820EF1D-F798-41F6-8B73-84AB8DFB2D07 @default.
- Q95290767 P2093 Q95290767-B9654B38-17AF-46D9-9D88-A24244D92733 @default.
- Q95290767 P2093 Q95290767-BF8729FA-5DFB-438A-8CC4-D0E39C6F984F @default.
- Q95290767 P2093 Q95290767-E51D0CD3-D662-4612-9737-9D5E64DF93F8 @default.
- Q95290767 P2093 Q95290767-F8E38735-DF2F-445F-A0B8-89ACFD9BFE5D @default.
- Q95290767 P275 Q95290767-fcdb3e16-095c-47ac-9cc0-444bb0ab3b4d @default.
- Q95290767 P304 Q95290767-BBA27FAF-1EEE-43F9-A38B-A930434F93CE @default.
- Q95290767 P31 Q95290767-E61EAE1A-A5F1-4A6F-B2E0-B371451C8E58 @default.
- Q95290767 P356 Q95290767-DE3DABED-126F-4C7B-A706-DBCBECE3A9F7 @default.
- Q95290767 P478 Q95290767-83986879-16C5-4EF6-926C-B24B58CFBC4E @default.
- Q95290767 P50 Q95290767-43A76521-A018-40EA-9158-716FE2935652 @default.
- Q95290767 P50 Q95290767-50A60873-4868-4E7D-945A-0C84CB1DE4D0 @default.
- Q95290767 P577 Q95290767-A7D96DFB-F241-46CB-8C72-CA90D976B7AA @default.
- Q95290767 P6216 Q95290767-b888c373-21c5-4583-80ed-c663e941cfc3 @default.
- Q95290767 P698 Q95290767-298794D4-0C37-4440-8776-9854772CA4A5 @default.
- Q95290767 P932 Q95290767-04DACC85-9771-4E95-9157-DCBECB656BFC @default.
- Q95290767 P356 CLEP.S242065 @default.
- Q95290767 P698 32431551 @default.
- Q95290767 P1433 Q5133758 @default.
- Q95290767 P1476 "Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries" @default.
- Q95290767 P2093 "Daniel Prieto-Alhambra" @default.
- Q95290767 P2093 "Elisabeth Smits" @default.
- Q95290767 P2093 "Fabian Hoti" @default.
- Q95290767 P2093 "Fernie J A Penning-van Beest" @default.
- Q95290767 P2093 "Helen P Booth" @default.
- Q95290767 P2093 "Irene D Bezemer" @default.
- Q95290767 P2093 "Kwame Appenteng" @default.
- Q95290767 P2093 "Minna Vehkala" @default.
- Q95290767 P2093 "Noah Jamie Robinson" @default.
- Q95290767 P2093 "Stefan de Vogel" @default.
- Q95290767 P2093 "Ying He" @default.
- Q95290767 P275 Q18810331 @default.
- Q95290767 P304 "423-433" @default.
- Q95290767 P31 Q13442814 @default.
- Q95290767 P356 "10.2147/CLEP.S242065" @default.
- Q95290767 P478 "12" @default.
- Q95290767 P50 Q89566586 @default.
- Q95290767 P50 Q95290761 @default.
- Q95290767 P577 "2020-05-01T00:00:00Z" @default.
- Q95290767 P6216 Q50423863 @default.
- Q95290767 P698 "32431551" @default.
- Q95290767 P932 "7200224" @default.